Works matching IS 1082801X AND DT 2004 AND VI 39 AND IP 10
Results: 20
Vancomycin resistance: means of prevention, control, and treatment revisited.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Cinacalcet: the first calcimimetic approved for secondary hyperparathyroidism.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
FDA to adopt new pediatric suicidality warning for antidepressant labelling.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 478
- Publication type:
- Article
Anxiety and sleep disorders.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 508
- Publication type:
- Article
Drug Watch.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 508
- Publication type:
- Article
New efforts to spur antimicrobial research gain momentum.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 507
- Publication type:
- Article
Purchasing pools yield more options, savings for states.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 507
- Publication type:
- Article
Government seeks posting of clinical trial results online.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 507
- Publication type:
- Article
'Roadmap' developed to prepare for and respond to pandemic.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 506
- Publication type:
- Article
Electronic database allows greater public access to studies.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 506
- Publication type:
- Article
FDA combats illegal WWW drug sales.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 506
- Publication type:
- Article
Vancomycin resistance: Means of prevention, control, and treatment revisited.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 490
- By:
- Publication type:
- Article
Cinacalcet.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 482
- By:
- Publication type:
- Article
Pregabalin demonstrates sustained efficacy in treating neuropathic pain.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 480
- Publication type:
- Article
Pipeline preview.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 476
- Publication type:
- Article
Rofecoxib voluntarily withdrawn from market due to cardiovascular risk.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 478
- Publication type:
- Article
New formulations.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 476
- Publication type:
- Article
New indications.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 476
- Publication type:
- Article
High-dose simvastatin fails to achieve primary end point in trial of ACS.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 480
- Publication type:
- Article
FDA actions in brief.
- Published in:
- Formulary, 2004, v. 39, n. 10, p. 477
- Publication type:
- Article